Computational and Structural Biotechnology Journal,
Journal Year:
2024,
Volume and Issue:
23, P. 929 - 941
Published: Feb. 1, 2024
Cancer
immunotherapy
has
shown
to
be
a
promising
method
in
treating
hepatocellular
carcinoma
(HCC),
but
suboptimal
responses
patients
are
attributed
the
cellular
and
molecular
heterogeneity.
Iron
metabolism-related
genes
(IRGs)
important
maintaining
immune
system
homeostasis
have
potential
help
developed
new
strategies
for
HCC
treatment.
Herein,
we
constructed
validated
iron-metabolism
gene
prognostic
index
(IPX)
using
univariate
cox
proportional
hazards
regression
LASSO
analysis,
successfully
categorizing
into
two
groups
with
distinct
survival
risk.
Then,
performed
single-sample
set
enrichment
weighted
correlation
network
ontology
lineage
analysis
SCENIC
reveal
key
determinants
underlying
ability
of
this
model
based
on
bulk
single-cell
transcriptomic
data.
We
identified
several
driver
transcription
factors
specifically
activated
specific
malignant
cell
sub-populations
contribute
adverse
outcomes
IPX-high
subgroup.
Within
tumor
microenvironment
(TME),
T
cells
displayed
significant
diversity
their
characteristics
experienced
changes
developmental
paths
within
clusters
by
IPX.
Interestingly,
proportion
Treg
was
increased
high-risk
group
compared
low-risk
group.
These
results
suggest
that
could
involved
reshaping
TME,
thereby
disrupting
cycle
cells.
This
study
utilized
IRGs
construct
novel
reliable
model,
which
can
used
assessing
prognosis
further
clarified
mechanisms
at
resolution.
Antioxidants,
Journal Year:
2022,
Volume and Issue:
11(12), P. 2444 - 2444
Published: Dec. 11, 2022
SLC7A11
is
a
cell
transmembrane
protein
composing
the
light
chain
of
system
xc-,
transporting
extracellular
cystine
into
cells
for
cysteine
production
and
GSH
biosynthesis.
critical
gateway
redox
homeostasis
by
maintaining
cellular
levels
that
counter
oxidative
stress
suppress
ferroptosis.
overexpressed
in
various
human
cancers
regulates
tumor
development,
proliferation,
metastasis,
microenvironment,
treatment
resistance.
Upregulation
needed
to
adapt
high
microenvironments
maintain
homeostasis.
High
basal
ROS
dependences
cancer
render
them
vulnerable
further
stress.
Therefore,
cyst(e)ine
depletion
may
be
an
effective
new
strategy
treatment.
However,
effectiveness
inhibitors
or
cyst(e)inase
has
been
established
many
preclinical
studies
but
not
reached
stage
clinical
trials
patients.
A
better
understanding
functions
regulating
interacting
with
redox-active
proteins
their
substrates
could
promising
this
review
intends
understand
role
antioxidant
signaling,
regulators
bioavailability
cancer,
linking
signaling
metabolism
targeting
novel
therapeutics.
Cell Death Discovery,
Journal Year:
2023,
Volume and Issue:
9(1)
Published: March 8, 2023
Reprogramming
of
lipid
metabolism,
which
modulates
energy
utilization
and
cell
signaling,
maintains
survival
promotes
cancer
metastasis
in
cells.
Ferroptosis
is
a
type
necrosis
caused
by
an
overload
oxidation,
has
been
demonstrated
to
be
involved
metastasis.
However,
the
mechanism
fatty
acid
metabolism
regulates
anti-ferroptosis
signaling
pathways
not
fully
understood.
The
formation
ovarian
spheroids
helps
counteract
hostile
microenvironment
peritoneal
cavity
with
low
oxygen,
shortage
nutrients,
subjected
platinum
therapy.
Previously,
we
that
Acyl-CoA
synthetase
long-chain
family
member
1
(ACSL1)
metastases
cancer,
but
still
well
elucidated.
In
this
study,
demonstrate
under
exposure
chemotherapy
increased
levels
proteins
as
ACSL1.
Inhibition
ferroptosis
can
enhance
spheroid
vice
versa.
Genetic
manipulation
ACSL1
expression
showed
reduced
level
oxidation
resistance
ferroptosis.
Mechanistically,
N-myristoylation
suppressor
(FSP1),
resulting
inhibition
its
degradation
translocation
membrane.
increase
myristoylated
FSP1
functionally
counteracted
oxidative
stress-induced
Clinical
data
also
suggested
protein
was
positively
correlated
negatively
markers
4-HNE
PTGS2.
conclusion,
study
enhances
antioxidant
capacity
increases
modulating
myristoylation
FSP1.
Cell Death and Disease,
Journal Year:
2024,
Volume and Issue:
15(2)
Published: Feb. 15, 2024
Abstract
Cancer
cells
develop
multiple
strategies
to
evade
T
cell-mediated
killing.
On
one
hand,
cancer
may
preferentially
rely
on
certain
amino
acids
for
rapid
growth
and
metastasis.
the
other
sufficient
nutrient
availability
uptake
are
necessary
mounting
an
effective
cell
anti-tumor
response
in
tumor
microenvironment
(TME).
Here
we
demonstrate
that
outcompete
cystine
due
high
Slc7a11
expression.
This
competition
induces
T-cell
exhaustion
ferroptosis,
characterized
by
diminished
memory
formation
cytokine
secretion,
increased
PD-1
TIM-3
expression,
as
well
intracellular
oxidative
stress
lipid-peroxide
accumulation.
Importantly,
either
deletion
or
intratumoral
supplementation
improves
immunity.
Mechanistically,
deprivation
disrupts
glutathione
synthesis,
but
promotes
CD36
mediated
lipid
dysregulated
cystine/glutamate
exchange.
Moreover,
enforced
expression
of
glutamate-cysteine
ligase
catalytic
subunit
(Gclc)
synthesis
prevents
upregulation,
thus
boosting
Our
findings
reveal
metabolic
checkpoint
orchestrates
survival
differentiation,
highlight
Gclc
a
potential
therapeutic
target
enhancing
function.
Small,
Journal Year:
2024,
Volume and Issue:
20(25)
Published: Jan. 25, 2024
Abstract
The
growth
state
of
tumor
cells
is
strictly
affected
by
the
specific
abnormal
redox
status
microenvironment
(TME).
Moreover,
reactions
at
biological
level
are
also
central
and
fundamental
to
essential
energy
metabolism
in
tumors.
Accordingly,
anti‐tumor
nanodrugs
targeting
disruption
this
homeostasis
have
become
one
hot
spots
field
research
due
effectiveness
TME
modulation
efficiency
mediated
interference.
This
review
discusses
latest
results
therapy,
which
regulate
levels
oxidants
or
reductants
through
a
variety
therapeutic
strategies,
ultimately
breaking
original
“stable”
promoting
cell
death.
With
gradual
deepening
study
on
vigorous
development
nanomaterials,
it
expected
that
more
nano
drugs
based
regulation
will
be
designed
even
applied
clinically.
Clinical and Experimental Medicine,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: Jan. 3, 2025
Donafenib
is
an
improved
version
of
sorafenib
in
which
deuterium
substituted
into
the
drug's
chemical
structure,
enhancing
its
stability
and
antitumor
activity.
exhibits
enhanced
activity
better
tolerance
than
preclinical
clinical
studies.
However,
specific
mechanism
effect
on
hepatocellular
carcinoma
has
not
been
reported.
Iron
deposition
a
cell
death
pattern
caused
by
disturbances
iron
metabolism.
Apoptosis
form
programmed
death.
They
may
interact
with
each
other
during
This
study
mainly
explores
potential
donafenib
activating
p53
signaling
pathway,
inducing
deposition,
apoptosis
carcinoma.
Hepa1-6
Huh7
cells
were
treated
various
concentrations
donafenib.
Scratch
healing
pore
migration
tests
conducted.
Analyze
through
flow
cytometry
TUNEL
fluorescence
labeling.
RNA
sequencing
was
conducted
both
untreated
donafenib-treated
cells.
The
key
proteins
involved
ferroptosis
(SLC7A11,
GPX4)
(caspase3,
caspase8,
Bax,
Bcl-2,
p53)
then
evaluated
using
immunoblotting
immunohistochemical
staining.
Reactive
oxygen
species
(ROS)
levels
cancer
measured.
treatment
resulted
dose-dependent
decrease
proliferation,
migration,
invasion
capabilities
There
increase
rates
ROS
accumulation,
reduction
tumor
volume.
underwent
significant
changes.
activates
induce
ferroptosis,
enhance
apoptosis,
suggesting
as
effective
therapeutic
agent
for
HCC.
Cancer Cell International,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: June 6, 2023
Abstract
Background
Malignant
transformation
from
hepatic
fibrosis
to
carcinogenesis
may
be
a
therapeutic
target
for
hepatocellular
carcinoma
(HCC).
The
aim
of
this
study
was
evaluate
anti-cancer
efficacy
Pien-Tze-Huang
(PZH),
and
investigate
the
underlying
mechanisms
by
integrating
transcriptional
regulatory
network
analysis
experimental
validation.
Methods
A
diethylnitrosamine
(DEN)-induced
HCC
model
in
rats
established
used
PZH.
After
detecting
transcriptomic
profiling,
“disease-related
gene–drug
effective
target”
interaction
constructed,
candidate
targets
PZH
against
malignant
were
identified
verified
vitro.
Results
effectively
alleviated
pathological
changes
cirrhosis,
inhibited
tumor
formation
growth
DEN-induced
rats.
Additionally,
administration
reduced
levels
various
function-related
serological
indicators
significantly.
Mechanically,
ferroptosis-related
SLC7A11-GSH-GPX4
axis
might
one
potential
HCC.
Especially,
high
SLC7A11
expression
associated
with
poor
prognosis
patients.
Experimentally,
markedly
increased
trivalent
iron
ferrous
ion,
suppressed
GPX4
proteins,
GSH/GSSG
ratio
liver
tissues
Conclusions
Our
data
offer
an
evidence
that
improve
microenvironment
prevent
occurrence
through
promoting
ferroptosis
cells
via
inhibiting
axis,
implying
drug
prevention
treatment
at
early
stage.
Biomarker Research,
Journal Year:
2024,
Volume and Issue:
12(1)
Published: April 29, 2024
Abstract
Cell
death
is
an
important
part
of
the
life
cycle,
serving
as
a
foundation
for
both
orderly
development
and
maintenance
physiological
equilibrium
within
organisms.
This
process
fundamental,
it
eliminates
senescent,
impaired,
or
aberrant
cells
while
also
promoting
tissue
regeneration
immunological
responses.
A
novel
paradigm
programmed
cell
death,
known
disulfidptosis,
has
recently
emerged
in
scientific
circle.
Disulfidptosis
defined
accumulation
cystine
by
cancer
with
high
expression
solute
carrier
family
7
member
11
(SLC7A11)
during
glucose
starvation.
causes
extensive
disulfide
linkages
between
F-actins,
resulting
their
contraction
subsequent
detachment
from
cellular
membrane,
triggering
death.
The
RAC1-WRC
axis
involved
this
phenomenon.
sparked
growing
interest
due
to
its
potential
applications
variety
pathologies,
particularly
oncology,
neurodegenerative
disorders,
metabolic
anomalies.
Nonetheless,
complexities
regulatory
pathways
remain
elusive,
precise
molecular
targets
have
yet
be
definitively
identified.
manuscript
aims
meticulously
dissect
historical
evolution,
underpinnings,
frameworks,
implications
disulfidptosis
various
disease
contexts,
illuminating
promise
groundbreaking
therapeutic
pathway
target.
Frontiers in Endocrinology,
Journal Year:
2024,
Volume and Issue:
14
Published: Jan. 4, 2024
Ferroptosis
is
a
type
of
controlled
cell
death
caused
by
lipid
peroxidation,
which
results
in
the
rupture
membrane.
ferroptosis
has
been
repeatedly
demonstrated
over
past
ten
years
to
be
significant
factor
number
diseases.
The
liver
iron
storage
organ,
thus
will
have
great
potential
treatment
particularly
prevalent
HCC.
In
opening
section
this
article,
we
give
general
summary
pertinent
molecular
mechanisms,
signaling
pathways,
and
associated
characteristics
ferroptosis.
primary
regulating
mechanisms
during
are
then
briefly
discussed,
conclude
summarizing
development
novel
therapeutic
strategies
used
treat
HCC
recent
years.
crucial
strategy
for
offers
new
perspectives
on
cancer.